US Lifts Tariffs on Indian Tea, Coffee & Spices
India to gain modestly as US removes reciprocal tariffs on agricultural products including tea, coffee and spices. Experts say benefits may be limited without infrastructure upgrades.
Category : Search result: Indian pharma exports
India's US exports grow despite 50% Trump tariffs
India's exports to US show 14.5% monthly growth despite 50% tariffs, though down 8.58% year-on-year. Gold imports surge 188.2% while gems exports decline 29.5%. Read full analysis.
India's exports fall 12% in October, trade deficit widens
India's merchandise exports declined by nearly 12% in October 2024, while trade deficit expanded to $41.68 billion. Key sectors show mixed performance amid global challenges.
Remedium Lifecare Q2 Profit Jumps 92% to ₹38.62 Cr
Remedium Lifecare reports stellar Q2 results with profit nearly doubling to ₹38.62 crore. Revenue surges 22% driven by strong pharmaceutical exports and domestic growth.
India's October exports fall to $34.38B, deficit widens
India's merchandise exports declined to $34.38 billion in October as US tariff hikes take effect. Trade deficit widened to $41.68 billion. Read analysis of economic impact.
US Tariff Relief to Add $3 Billion to Indian Exports
Indian exports set to gain $2.5-3 billion from US tariff exemptions. High-value agricultural products lead the boost, but challenges remain. Read full analysis.
US Tariff Cuts Boost Indian Spice and Tea Exports
US President Trump reduces import duties on 200 items, benefiting Indian spice merchants and tea growers. Indian exports worth $500M get competitive edge amid trade tensions.
Trump Reduces Tariffs on Indian Food Products
Former President Donald Trump announces significant tariff reductions on Indian agricultural exports including beef, coffee, and processed foods, boosting trade relations.
European Pharma Stocks Rebound from AI Shift
European weight-loss drug makers surge as investors rotate capital from expensive AI stocks into healthcare. Zealand Pharma leads with a 20% weekly jump. Explore the market dynamics.
Purdue Pharma Wins Bankruptcy Approval in Opioid Case
Purdue Pharma receives court approval for $7.4 billion opioid settlement after Supreme Court intervention. Sackler family to pay $6.5 billion over 15 years in landmark case.
Purdue Pharma $7B Opioid Settlement Gets Court Nod
Federal judge approves Purdue Pharma's bankruptcy plan requiring Sackler family to pay $7 billion and surrender company ownership. Thousands of opioid victims to receive compensation in historic settlement.
Lincoln Pharma Aims for Rs 1000 Crore Revenue
Lincoln Pharmaceuticals Ltd announces ambitious plan to achieve Rs 1000 crore revenue within three years through strategic expansion and new product launches. Read more about their growth strategy.
OneSource Pharma Raises FY28 Revenue Target to $500M
OneSource Pharma hikes FY28 revenue guidance to over $500 million, plans $100M expansion for weight-loss drugs like semaglutide. CEO reveals accelerated growth strategy.
₹45,060 Crore Export Boost Scheme Announced for MSMEs
Indian government unveils massive ₹45,060 crore scheme to boost exports, support MSMEs, and enhance global competitiveness. Key initiatives include interest equalization and TIES renewal.
Gujarat Pharma Factory Blast: 2 Dead, 20 Injured
Tragic boiler explosion at pharmaceutical factory in Gujarat's Bharuch district claims 2 lives, leaves 20 injured. Massive fire brought under control by emergency teams.
India's Drug Regulator Tightens Pharma Quality Control
India's DCGI orders nationwide inspections of small pharma units as WHO flags toxic cough syrups. MSMEs struggle to meet new Schedule M compliance deadline of January 2026.
Indian Pharma Units Face Closure Over GMP Non-Compliance
DCGI directs state authorities to enforce strict GMP compliance by December 31, 2025. Delhi, Himachal Pradesh, Uttarakhand already taking action against non-compliant manufacturers.
DCGI Orders Global Pharma Standards Implementation by Jan 2026
India's drug regulator DCGI mandates global manufacturing standards for all pharma companies by January 2026. State regulators ordered to begin inspections immediately. Read about the strict compliance requirements.
Sun Pharma: US Tariff Clarity & Q2 FY26 Outlook
Sun Pharma investors await Q2 FY26 results with cautious optimism as US tariff clarity emerges. Discover how import duties and market dynamics could impact India's pharmaceutical giant.
Indian Pharma Soars with Record US Generic Drug Profits
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
AstraZeneca Q3 Profit Jumps 77% to $2.53 Billion
British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.
Piramal Pharma Bets on US Biopharma Funding Revival
Piramal Pharma anticipates significant growth as US biopharma funding shows recovery signs, with CDMO business poised for major expansion.
India's Fuel Exports Plunge 21% in October
India witnessed a dramatic 21% drop in fuel exports during October as domestic demand surged unexpectedly. Major refiners HPCL and Nayara Energy faced significant operational disruptions, reshaping the country's energy export landscape.
Solara Pharma Q2 Loss: ₹10 Crore Amid Challenges
Solara Active Pharma Sciences faces challenging quarter with ₹10 crore net loss despite revenue growth. Discover the operational challenges and management's recovery strategy.
Sun Pharma Q2 Profit Rises 2.5% to ₹3,118 Crore
India's pharmaceutical giant Sun Pharma reports steady Q2 growth with 9% revenue increase while navigating US market challenges. Key insights from their latest earnings report.
Navin Fluorine Shares Surge 22% in 3 Sessions
Discover why Navin Fluorine International shares skyrocketed 22% in just three trading sessions. Expert analysis reveals the key drivers behind this chemical sector powerhouse's impressive rally and what investors should watch next.
Q2 Results Today: Sun Pharma, Grasim, Britannia Earnings
Market eyes Wednesday's Q2 earnings bonanza as pharma giant Sun Pharma, Grasim Industries, and FMCG major Britannia declare results. Get complete analysis and investor expectations.
India's Export Growth Defies US Tariff Challenges
India's exports surged 13% in September despite US tariff pressures and declining service exports. Discover how manufacturing resilience is driving growth amid global trade uncertainties.
US Eyes India as Major Market for Energy Exports
As India's energy consumption skyrockets, the United States positions itself as a key supplier, eyeing massive export opportunities in one of the world's fastest-growing markets.
India's Gems Sector Eyes $100B Exports by 2047
India's gem and jewellery industry sets ambitious target to surpass $100 billion in exports by 2047, backed by strategic initiatives and global market expansion plans.
Page 1 of 4